Difference in solute excretion during correction of hyponatremic patients with cirrhosis or syndrome of inappropriate secretion of antidiuretic hormone by oral vasopressin V2 receptor antagonist VPA-985

Journal of Laboratory and Clinical Medicine

Volumn 138, Issue 1, 2001, Pages 18-21

  Decaux, G ^a,b  

^a Service De Médecine Interne Générale   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034962769     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2001.116025     Document Type: Article

References (15)

1. Hyponatremia: A prospective analysis of its epidemiology and the pathogenic role of vasopressin
2. The syndrome of inappropriate secretion of antidiuretic hormone
3. Effect of vasopressin V1 (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function
4. VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist
5. Treatment of hyponatremia with VPA-985
6. Hypouremia in the syndrome of inappropriate secretion of antidiuretic hormone
7. Dissociation between uric acid and urea clearances in the syndrome of inappropriate secretion of antidiuretic hormone related to salt excretion
8. Elevation of uric acid clearance caused by inappropriate antidiuretic hormone secretion
9. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone
10. Antidiuretic hormone and renal clearance of uric acid
11. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia
12. Effect of urine flow rate on urea reabsorption in man: Urea as a "tubular marker"
13. Effect of demeclocycline on renal function and urinary prostaglandin E2 and kallikrein in hyponatremic cirrhosis
14. Urea for the treatment of water retention in hyponatremic cirrhosis with ascites resistant to diuretics
15. Treatment of hyponatremic cirrhosis with ascites resistant to diuretics by urea